Does sarcopenia affect postoperative short- and long-term outcomes in patients with lung cancer?-a systematic review and meta-analysis.

1. Cruz-Jentoft AJ, Baeyens JP, Bauer JM, et al. Sarcopenia:

European consensus on definition and diagnosis: Report

of the European Working Group on Sarcopenia in Older

People. Age Ageing 2010;39:412-23.

2. Fearon KC. Cancer cachexia and fat-muscle physiology. N

Engl J Med 2011;365:565-7.

3. Harimoto N, Yoshizumi T, Shimokawa M, et al.

Sarcopenia is a poor prognostic factor following hepatic

resection in patients aged 70 years and older with

hepatocellular carcinoma. Hepatol Res 2016;46:1247-55.

4. Villaseñor A, Ballard-Barbash R, Baumgartner K, et al.

Prevalence and prognostic effect of sarcopenia in breast

cancer survivors: the HEAL Study. J Cancer Surviv

2012;6:398-406.

5. Levolger S, van Vugt JL, de Bruin RW, et al. Systematic

review of sarcopenia in patients operated on for

gastrointestinal and hepatopancreatobiliary malignancies.

Br J Surg 2015;102:1448-58.

6. Stene GB, Helbostad JL, Amundsen T, et al. Changes

in skeletal muscle mass during palliative chemotherapy

in patients with advanced lung cancer. Acta Oncol

2015;54:340-8.

7. Ozeki N, Kawaguchi K, Fukui T, et al. Psoas muscle mass

in patients undergoing lung cancer surgery: a prognostic

difference between squamous cell carcinoma and

adenocarcinoma. Int J Clin Oncol 2020;18:020-01624.

8. Nakamura R, Inage Y, Tobita R, et al. Sarcopenia in

Resected NSCLC: Effect on Postoperative Outcomes. J

Thorac Oncol 2018;13:895-903.

9. Suzuki Y, Okamoto T, Fujishita T, et al. Clinical

implications of sarcopenia in patients undergoing complete

resection for early non-small cell lung cancer. Lung

Cancer 2016;101:92-7.

10. Tsukioka T, Nishiyama N, Izumi N, et al. Sarcopenia

is a novel poor prognostic factor in male patients with

pathological Stage I non-small cell lung cancer. Jpn J Clin

Oncol 2017;47:363-8.

11. Tsukioka T, Izumi N, Mizuguchi S, et al. Positive

correlation between sarcopenia and elevation of

neutrophil/lymphocyte ratio in pathological stage IIIA

(N2-positive) non-small cell lung cancer patients. Gen

Thorac Cardiovasc Surg 2018;66:716-22.

12. Shoji F, Matsubara T, Kozuma Y, et al. Relationship Between

J Thorac Dis 2021;13(3):1358-1369 | http://dx.doi.org/10.21037/jtd-20-3072

1368

13. 14. 15. 16. 17. 18. 19. 20. 21. 22. 23. 24. 25. Preoperative Sarcopenia Status and Immuno-nutritional

Parameters in Patients with Early-stage Non-small Cell

Lung Cancer. Anticancer Res 2017;37:6997-7003.

Kim EY, Lee HY, Kim KW, et al. Preoperative Computed

Tomography-Determined Sarcopenia and Postoperative

Outcome After Surgery for Non-Small Cell Lung Cancer.

Scand J Surg 2018;107:244-51.

Kawaguchi Y, Hanaoka J, Ohshio Y, et al. Sarcopenia

predicts poor postoperative outcome in elderly patients

with lung cancer. Gen Thorac Cardiovasc Surg

2019;67:949-54.

Shinohara S, Otsuki R, Kobayashi K, et al. Impact of

Sarcopenia on Surgical Outcomes in Non-small Cell Lung

Cancer. Ann Surg Oncol 2020;22:020-08224.

Icard P, Schussler O, Loi M, et al. Pre-Disease and PreSurgery BMI, Weight Loss and Sarcopenia Impact Survival

of Resected Lung Cancer Independently of Tumor Stage.

Cancers (Basel) 2020;12:266.

Deng HY, Hou L, Zha P, et al. Sarcopenia is an

independent unfavorable prognostic factor of non-small

cell lung cancer after surgical resection: A comprehensive

systematic review and meta-analysis. Eur J Surg Oncol

2019;45:728-35.

Kawaguchi Y, Hanaoka J, Oshio Y, et al. Decrease in

performance status after lobectomy mean poor prognosis in

elderly lung cancer patients. J Thorac Dis 2017;9:1525-30.

Pedersen BK, Febbraio MA. Muscles, exercise and obesity:

skeletal muscle as a secretory organ. Nat Rev Endocrinol

2012;8:457-65.

Benatti FB, Pedersen BK. Exercise as an anti-inflammatory

therapy for rheumatic diseases-myokine regulation. Nat

Rev Rheumatol 2015;11:86-97.

Hojman P, Dethlefsen C, Brandt C, et al. Exercise-induced

muscle-derived cytokines inhibit mammary cancer cell

growth. Am J Physiol Endocrinol Metab 2011;301:E504.

Aoi W, Naito Y, Takagi T, et al. A novel myokine, secreted

protein acidic and rich in cysteine (SPARC), suppresses

colon tumorigenesis via regular exercise. Gut 2013;62:882-9.

Lucia A, Ramirez M. Muscling In on Cancer. N Engl J

Med 2016;375:892-4.

Dethlefsen C, Hansen LS, Lillelund C, et al. ExerciseInduced Catecholamines Activate the Hippo Tumor

Suppressor Pathway to Reduce Risks of Breast Cancer

Development. Cancer Res 2017;77:4894-904.

Simonsen C, de Heer P, Bjerre ED, et al. Sarcopenia

and Postoperative Complication Risk in Gastrointestinal

Surgical Oncology: A Meta-analysis. Ann Surg

2018;268:58-69.

© Journal of Thoracic Disease. All rights reserved.

Kawaguchi et al. Sarcopenia and lung cancer surgery

26. Peyton CC, Heavner MG, Rague JT, et al. Does

Sarcopenia Impact Complications and Overall Survival in

Patients Undergoing Radical Nephrectomy for Stage III

and IV Kidney Cancer? J Endourol 2016;30:229-36.

27. Reisinger KW, Derikx JP, van Vugt JL, et al. Sarcopenia

is associated with an increased inflammatory response to

surgery in colorectal cancer. Clin Nutr 2016;35:924-7.

28. Hamaguchi Y, Kaido T, Okumura S, et al. Proposal

for new diagnostic criteria for low skeletal muscle mass

based on computed tomography imaging in Asian adults.

Nutrition 2016;32:1200-5.

29. Christensen JF, Jones LW, Andersen JL, et al. Muscle

dysfunction in cancer patients. Ann Oncol 2014;25:947-58.

30. Papadimitriou N, Dimou N, Tsilidis KK, et al. Physical

activity and risks of breast and colorectal cancer: a

Mendelian randomisation analysis. Nat Commun

2020;11:020-14389.

31. Monninkhof EM, Elias SG, Vlems FA, et al. Physical

activity and breast cancer: a systematic review.

Epidemiology 2007;18:137-57.

32. Chen X, Lu W, Zheng W, et al. Exercise after diagnosis of

breast cancer in association with survival. Cancer Prev Res

(Phila) 2011;4:1409-18.

33. Irwin ML, Smith AW, McTiernan A, et al. Influence of

pre- and postdiagnosis physical activity on mortality in

breast cancer survivors: the health, eating, activity, and

lifestyle study. J Clin Oncol 2008;26:3958-64.

34. Kim EY, Kim K, Kim YS, et al. Prevalence of and Factors

Associated with Sarcopenia in Korean Cancer Survivors:

Based on Data Obtained by the Korea National Health

and Nutrition Examination Survey (KNHANES) 20082011. Nutr Cancer 2017;69:394-401.

35. van der Meij BS, Langius JA, Smit EF, et al. Oral

nutritional supplements containing (n-3) polyunsaturated

fatty acids affect the nutritional status of patients with

stage III non-small cell lung cancer during multimodality

treatment. J Nutr 2010;140:1774-80.

36. Solheim TS, Laird BJA, Balstad TR, et al. A randomized

phase II feasibility trial of a multimodal intervention for

the management of cachexia in lung and pancreatic cancer.

J Cachexia Sarcopenia Muscle 2017;8:778-88.

37. Naito T, Mitsunaga S, Miura S, et al. Feasibility of

early multimodal interventions for elderly patients with

advanced pancreatic and non-small-cell lung cancer. J

Cachexia Sarcopenia Muscle 2019;10:73-83.

38. Katakami N, Uchino J, Yokoyama T, et al. Anamorelin

(ONO-7643) for the treatment of patients with non-small

cell lung cancer and cachexia: Results from a randomized,

J Thorac Dis 2021;13(3):1358-1369 | http://dx.doi.org/10.21037/jtd-20-3072

Journal of Thoracic Disease, Vol 13, No 3 March 2021

double-blind, placebo-controlled, multicenter study of

Japanese patients (ONO-7643-04). Cancer 2018;124:606-16.

39. Stewart Coats AJ, Ho GF, Prabhash K, et al. Espindolol

for the treatment and prevention of cachexia in patients

with stage III/IV non-small cell lung cancer or colorectal

cancer: a randomized, double-blind, placebo-controlled,

international multicentre phase II study (the ACT-ONE

trial). J Cachexia Sarcopenia Muscle 2016;7:355-65.

40. Busquets S, Toledo M, Orpi M, et al. Myostatin blockage

using actRIIB antagonism in mice bearing the Lewis lung

1369

carcinoma results in the improvement of muscle wasting

and physical performance. J Cachexia Sarcopenia Muscle

2012;3:37-43.

41. Steffl M, Bohannon RW, Petr M, et al. Relation between

cigarette smoking and sarcopenia: meta-analysis. Physiol

Res 2015;64:419-26.

42. Landi F, Marzetti E, Martone AM, et al. Exercise as a

remedy for sarcopenia. Curr Opin Clin Nutr Metab Care

2014;17:25-31.

Cite this article as: Kawaguchi Y, Hanaoka J, Ohshio Y,

Okamoto K, Kaku R, Hayashi K, Shiratori T, Akazawa A. Does

sarcopenia affect postoperative short- and long-term outcomes

in patients with lung cancer?—a systematic review and metaanalysis. J Thorac Dis 2021;13(3):1358-1369. doi: 10.21037/jtd-203072

© Journal of Thoracic Disease. All rights reserved.

J Thorac Dis 2021;13(3):1358-1369 | http://dx.doi.org/10.21037/jtd-20-3072

...